Correction to: Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.
作者信息
Luo Fan, Cao Jiaxin, Lu Feiteng, Zeng Kangmei, Ma Wenjuan, Huang Yan, Zhang Li, Zhao Hongyun
机构信息
Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, SunYat-Sen University Cancer Center, Guangzhou, China.
Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
出版信息
Cancer Cell Int. 2022 Jan 29;22(1):46. doi: 10.1186/s12935-022-02458-5.
Abstract
摘要
相似文献
1
Correction to: Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.对《鼻咽癌中淋巴细胞激活基因3蛋白表达与程序性细胞死亡蛋白1、程序性细胞死亡配体1及肿瘤浸润淋巴细胞的相关性》的更正
Cancer Cell Int. 2022 Jan 29;22(1):46. doi: 10.1186/s12935-022-02458-5.
2
Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.淋巴细胞激活基因3蛋白在鼻咽癌中的表达与程序性细胞死亡蛋白1、程序性细胞死亡配体1及肿瘤浸润淋巴细胞相关。
Cancer Cell Int. 2021 Aug 28;21(1):458. doi: 10.1186/s12935-021-02162-w.
3
Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages.基于程序性死亡配体 1 表达、肿瘤浸润淋巴细胞和巨噬细胞的存在来描述甲状旁腺癌和非典型肿瘤。
Surgery. 2018 Nov;164(5):960-964. doi: 10.1016/j.surg.2018.06.013. Epub 2018 Jul 20.
4
Predictive relevance of programmed cell death protein 1 and tumor-infiltrating lymphocyte expression in papillary thyroid cancer.程序性细胞死亡蛋白1及肿瘤浸润淋巴细胞表达在甲状腺乳头状癌中的预测相关性
Surgery. 2018 Jan;163(1):130-136. doi: 10.1016/j.surg.2017.04.033. Epub 2017 Nov 8.
5
Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.免疫检查点调节剂、细胞毒性 T 淋巴细胞抗原 4 和程序性死亡配体 1 在 Epstein-Barr 病毒相关鼻咽癌中的表达。
Appl Immunohistochem Mol Morphol. 2021 Jul 1;29(6):401-408. doi: 10.1097/PAI.0000000000000903.
6
Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.肿瘤浸润淋巴细胞中程序性死亡受体 1 表达与非小细胞肺癌中程序性死亡配体 1 表达的相关性。
Arch Pathol Lab Med. 2018 Nov;142(11):1388-1393. doi: 10.5858/arpa.2017-0516-OA. Epub 2018 Feb 12.
7
Expression and prognostic significance of programmed death protein 1 and programmed death ligand-1, and cytotoxic T lymphocyte-associated molecule-4 in hepatocellular carcinoma.程序性死亡蛋白1、程序性死亡配体-1及细胞毒性T淋巴细胞相关分子4在肝细胞癌中的表达及预后意义
APMIS. 2017 Aug;125(8):690-698. doi: 10.1111/apm.12703. Epub 2017 May 11.
8
Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder.程序性死亡配体-1 与肿瘤浸润淋巴细胞相关，并与膀胱癌的生存状况较差相关。
Cancer Sci. 2019 Feb;110(2):489-498. doi: 10.1111/cas.13887. Epub 2018 Dec 12.
9
Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis.程序性细胞死亡蛋白 1（PD-1）和程序性细胞死亡配体 1（PD-L1）在类风湿关节炎患者滑膜中的临床病理价值。
Clin Exp Med. 2018 Nov;18(4):487-494. doi: 10.1007/s10238-018-0515-4. Epub 2018 Jun 30.
10
Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma.PD-1与PD-L1的共表达预示着鼻咽癌的不良预后。
Med Oncol. 2015 Mar;32(3):86. doi: 10.1007/s12032-015-0501-6. Epub 2015 Feb 22.
本文引用的文献
1
Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.淋巴细胞激活基因3蛋白在鼻咽癌中的表达与程序性细胞死亡蛋白1、程序性细胞死亡配体1及肿瘤浸润淋巴细胞相关。
Cancer Cell Int. 2021 Aug 28;21(1):458. doi: 10.1186/s12935-021-02162-w.
Zotero 插件